Status:
COMPLETED
The Effect Of AVANDIA On The Late Asthmatic Response
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study is to investigate the effects of AVANDIA on the asthmatic response.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Mild asthmatic treated with short-acting beta agonists only, non-smoker.
- Exclusion criteria:
- Inability to abstain from medications other than short-acting beta agonists and paracetamol.
- Recent administration of steroids.
- Recent respiratory infection or exacerbation of asthma.
Exclusion
Key Trial Info
Start Date :
July 22 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2006
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00318630
Start Date
July 22 2005
End Date
June 30 2006
Last Update
September 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Wellington, New Zealand, 6035